Page 45 - Bio Engineering Approaches to Cancer Diagnosis and Treatment

42 CHAPTER 2 Diagnostic imaging in cancer

[22] O. Al-Bataineh, J. Jenne, P. Huber, Clinical and future applications of high intensity fo-
cused ultrasound in cancer, Cancer Treat. Rev. 38 (5) (2012) 346–353.
[23] F. Kiessling, S. Fokong, J. Bzyl, W. Lederle, M. Palmowski, T. Lammers, Recent ad-
vances in molecular, multimodal and theranostic ultrasound imaging, Adv. Drug Deliv.
Rev. 72 (2014) 15–27.
[24] D. Bokor, J.B. Chambers, P.J. Rees, T.G. Mant, F. Luzzani, A. Spinazzi, Clinical safety
of SonoVue™, a new contrast agent for ultrasound imaging, in healthy volunteers and
in patients with chronic obstructive pulmonary disease, Investig. Radiol. 36 (2) (2001)
104–109.
[25] S. Fokong, M. Siepmann, Z. Liu, G. Schmitz, F. Kiessling, J. Gätjens, Advanced char-
acterization and refinement of poly N-butyl cyanoacrylate microbubbles for ultrasound
imaging, Ultrasound Med. Biol. 37 (10) (2011) 1622–1634.
[26] G. Korpanty, P.A. Grayburn, R.V. Shohet, R.A. Brekken, Targeting vascular endothelium
with avidin microbubbles, Ultrasound Med. Biol. 31 (9) (2005) 1279–1283.
[27] S.R. Sirsi, M.A. Borden, Microbubble compositions, properties and biomedical applica-
tions, Bubble Sci. Eng. Technol. 1 (1–2) (2009) 3–17.
[28] M. Postema, G. Schmitz, Ultrasonic bubbles in medicine: influence of the shell, Ultrason.
Sonochem. 14 (4) (2007) 438–444.
[29] W.T. Joines, Y. Zhang, C. Li, R.L. Jirtle, The measured electrical properties of normal and
malignant human tissues from 50 to 900 MHz, Med. Phys. 21 (4) (1994) 547–550.
[30] Y. Liu, H. Wang, Nanomedicine: nanotechnology tackles tumours, Nat. Nanotechnol. 2
(1) (2007) 20.
[31] M. Xu, L.V. Wang, Photoacoustic imaging in biomedicine, Rev. Sci. Instrum. 77 (4)
(2006) 041101.
[32] L.A. Geddes, L.E. Baker, The specific resistance of biological material—a compendium of
data for the biomedical engineer and physiologist, Med. Biol. Eng. 5 (3) (1967) 271–293.
[33] R.J. Halter, A. Hartov, K.D. Paulsen, A broadband high-frequency electrical imped-
ance tomography system for breast imaging, IEEE Trans. Biomed. Eng. 55 (2) (2008)
650–659.
[34] L. Fass, Imaging and cancer: a review, Mol. Oncol. 2 (2) (2008) 115–152.
[35] A.P. Bagshaw, A.D. Liston, R.H. Bayford, A. Tizzard, A.P. Gibson, A.T. Tidswell, et al.
Electrical impedance tomography of human brain function using reconstruction algo-
rithms based on the finite element method, NeuroImage 20 (2) (2003) 752–764.
[36] Krebs, S., & Dunphy, M. (2017). Role of nuclear medicine in diagnosis and management
of hepatopancreatobiliary disease. In Blumgart’s Surgery of the Liver, Biliary Tract and
Pancreas, 2-Volume Set (pp. 285-315). Content Repository Only!.
[37] Fogelman, I., Cook, G., Israel, O., & Van der Wall, H. (2005, April). Positron emission
tomography and bone metastases. In Seminars in nuclear medicine (Vol. 35, No. 2, pp.
135-142). WB Saunders.
[38] G. Mariani, L. Moresco, G. Viale, G. Villa, M. Bagnasco, G. Canavese, et al. Radiogu-
ided sentinel lymph node biopsy in breast cancer surgery, J. Nucl. Med. 42 (8) (2001)
1198–1215.
[39] L.R. Coover, G. Caravaglia, P. Kuhn, Scintimammography with dedicated breast camera
detects and localizes occult carcinoma, J. Nucl. Med. 45 (4) (2004) 553–558.
[40] M.K. O’connor, S.W. Phillips, C.B. Hruska, D.J. Rhodes, D.A. Collins, Molecular breast
imaging: advantages and limitations of a scintimammographic technique in patients with
small breast tumors, Breast J. 13 (1) (2007) 3–11.